222 related articles for article (PubMed ID: 32687838)
1. Baicalin down-regulating hepatitis B virus transcription depends on the liver-specific HNF4α-HNF1α axis.
Xia C; Tang W; Geng P; Zhu H; Zhou W; Huang H; Zhou P; Shi X
Toxicol Appl Pharmacol; 2020 Sep; 403():115131. PubMed ID: 32687838
[TBL] [Abstract][Full Text] [Related]
2. Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs.
Huang H; Zhou W; Zhu H; Zhou P; Shi X
Toxicol Appl Pharmacol; 2017 May; 323():36-43. PubMed ID: 28322895
[TBL] [Abstract][Full Text] [Related]
3. Protocatechuic acid inhibits hepatitis B virus replication by activating ERK1/2 pathway and down-regulating HNF4α and HNF1α in vitro.
Dai XQ; Cai WT; Wu X; Chen Y; Han FM
Life Sci; 2017 Jul; 180():68-74. PubMed ID: 28504115
[TBL] [Abstract][Full Text] [Related]
4. Saikosaponin C exerts anti-HBV effects by attenuating HNF1α and HNF4α expression to suppress HBV pgRNA synthesis.
Pan Y; Ke Z; Ye H; Sun L; Ding X; Shen Y; Zhang R; Yuan J
Inflamm Res; 2019 Dec; 68(12):1025-1034. PubMed ID: 31531682
[TBL] [Abstract][Full Text] [Related]
5. A concerted action of HNF4alpha and HNF1alpha links hepatitis B virus replication to hepatocyte differentiation.
Quasdorff M; Hösel M; Odenthal M; Zedler U; Bohne F; Gripon P; Dienes HP; Drebber U; Stippel D; Goeser T; Protzer U
Cell Microbiol; 2008 Jul; 10(7):1478-90. PubMed ID: 18346225
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hepatitis B Virus replication by hepatocyte nuclear factor 4-alpha specific short hairpin RNA.
He F; Chen EQ; Liu L; Zhou TY; Liu C; Cheng X; Liu FJ; Tang H
Liver Int; 2012 May; 32(5):742-51. PubMed ID: 22340507
[TBL] [Abstract][Full Text] [Related]
7. Luteolin Inhibits Hepatitis B Virus Replication through Extracellular Signal-Regulated Kinase-Mediated Down-Regulation of Hepatocyte Nuclear Factor 4α Expression.
Bai L; Nong Y; Shi Y; Liu M; Yan L; Shang J; Huang F; Lin Y; Tang H
Mol Pharm; 2016 Feb; 13(2):568-77. PubMed ID: 26656210
[TBL] [Abstract][Full Text] [Related]
8. Neddylation inhibitor MLN4924 has anti-HBV activity via modulating the ERK-HNF1α-C/EBPα-HNF4α axis.
Xie M; Guo H; Lou G; Yao J; Liu Y; Sun Y; Yang Z; Zheng M
J Cell Mol Med; 2021 Jan; 25(2):840-854. PubMed ID: 33263949
[TBL] [Abstract][Full Text] [Related]
9. Novel mechanisms of regulation of the expression and transcriptional activity of hepatocyte nuclear factor 4α.
Guo S; Lu H
J Cell Biochem; 2019 Jan; 120(1):519-532. PubMed ID: 30191603
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of hepatocyte nuclear factor 1 and 4 alpha (HNF1α and HNF4α) as a mechanism of arsenic carcinogenesis.
Pastoret A; Marcos R; Sampayo-Reyes A; Saucedo-Cardenas O; Lozano-Garza GH; Hernandez A
Arch Toxicol; 2013 Jun; 87(6):1001-12. PubMed ID: 23052196
[TBL] [Abstract][Full Text] [Related]
11. Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4α in vitro and in vivo.
Zhao Z; Hong W; Zeng Z; Wu Y; Hu K; Tian X; Li W; Cao Z
J Biol Chem; 2012 Aug; 287(36):30181-90. PubMed ID: 22791717
[TBL] [Abstract][Full Text] [Related]
12. Suppression of Hepatocyte Nuclear Factor 4 α by Long-term Infection of Hepatitis B Virus Contributes to Tumor Cell Proliferation.
Park S; Ha YN; Dezhbord M; Lee AR; Park ES; Park YK; Won J; Kim NY; Choo SY; Shin JJ; Ahn CH; Kim KH
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023898
[TBL] [Abstract][Full Text] [Related]
13. Relationships between the expression of hepatocyte nuclear factors and factors essential for lipoprotein production in a human mesenchymal stem cell line, UE7T-13.
Sasaki A; Hiwatashi K; Kumagai M; Hata K; Kobayashi M
Biosci Biotechnol Biochem; 2017 Feb; 81(2):262-270. PubMed ID: 27838959
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte nuclear factors as possible C-reactive protein transcriptional inducer in the liver and white adipose tissue of rats with experimental chronic renal failure.
Sucajtys-Szulc E; Debska-Slizien A; Rutkowski B; Milczarek R; Pelikant-Malecka I; Sledzinski T; Swierczynski J; Szolkiewicz M
Mol Cell Biochem; 2018 Sep; 446(1-2):11-23. PubMed ID: 29330688
[TBL] [Abstract][Full Text] [Related]
15. Oxymatrine Inhibition of Hepatitis B Virus Replication Through ERK1/2 Pathway and HNF1α and HNF4α Block in vitro.
Wang F; Wang X; Ling B; Lu H; Huang J; Zhong T
J Coll Physicians Surg Pak; 2024 Mar; 34(3):329-335. PubMed ID: 38462870
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte nuclear factor 1α downregulates HBV gene expression and replication by activating the NF-κB signaling pathway.
Lin J; Gu C; Shen Z; Liu Y; Wang W; Tao S; Cui X; Liu J; Xie Y
PLoS One; 2017; 12(3):e0174017. PubMed ID: 28319127
[TBL] [Abstract][Full Text] [Related]
17. IL6 Inhibits HBV Transcription by Targeting the Epigenetic Control of the Nuclear cccDNA Minichromosome.
Palumbo GA; Scisciani C; Pediconi N; Lupacchini L; Alfalate D; Guerrieri F; Calvo L; Salerno D; Di Cocco S; Levrero M; Belloni L
PLoS One; 2015; 10(11):e0142599. PubMed ID: 26580974
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus suppresses Hepatocyte Nuclear Factor 4 alpha, a key regulator of hepatocellular carcinoma.
Vallianou I; Dafou D; Vassilaki N; Mavromara P; Hadzopoulou-Cladaras M
Int J Biochem Cell Biol; 2016 Sep; 78():315-326. PubMed ID: 27477312
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-35 stimulates hepatitis B virus transcription and replication by targeting transcription factor HNF4α.
Tao NN; Gong R; Chen X; He L; Ren F; Yu HB; Chen J; Ren JH
J Gen Virol; 2018 May; 99(5):645-654. PubMed ID: 29561254
[TBL] [Abstract][Full Text] [Related]
20. ERK1/2-HNF4α axis is involved in epigallocatechin-3-gallate inhibition of HBV replication.
Wang ZY; Li YQ; Guo ZW; Zhou XH; Lu MD; Xue TC; Gao B
Acta Pharmacol Sin; 2020 Feb; 41(2):278-285. PubMed ID: 31554961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
